Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo.

Toki S, Goleniewska K, Reiss S, Zhang J, Bloodworth MH, Stier MT, Zhou W, Newcomb DC, Ware LB, Stanwood GD, Galli A, Boyd KL, Niswender KD, Peebles RS
J Allergy Clin Immunol. 2018 142 (5): 1515-1528.e8

PMID: 29331643 · DOI:10.1016/j.jaci.2017.11.043

MeSH Terms (18)

Allergens Alternaria Animals Asthma Cytokines Dermatophagoides pteronyssinus Eosinophilia Female Glucagon-Like Peptide-1 Receptor Glucagon-Like Peptide 1 Immunity, Innate Interleukin-33 Lung Lymphocytes Mice, Inbred BALB C Mice, Transgenic Mucus Signal Transduction

Connections (1)

This publication is referenced by other Labnodes entities:

Links